Medication-Assisted Treatment in Oregon's Correctional System

Medication-assisted treatment, often called MAT or more precisely medication for opioid use disorder (MOUD), has become a central part of how Oregon approaches substance use care in jails and prisons. In simple terms, MAT combines approved medications with counseling and care planning to treat opioid use disorder. In Oregon, this is no longer a fringe idea or a pilot concept. It is part of the state's correctional health strategy, with active programs, grant funding, and reentry planning tied to jail and prison settings.

As of today, Oregon's approach reflects a broader public health shift: people in custody are still patients, and opioid use disorder is treated as a medical condition that can be managed with evidence-based care. The Oregon Health Authority describes MAT as a medically monitored therapeutic intervention that may include methadone and other medications, along with counseling and medication management. The Oregon Department of Corrections also provides health services to adults in custody, including ongoing treatment and pharmacy services. ([oregon.gov](https://www.oregon.gov/oha/hsd/amh/pages/mat.aspx))

Why MAT Matters in Jails and Prisons

Jails and prisons are high-risk settings for people with opioid use disorder. Withdrawal can begin quickly after incarceration, and the period after release is especially dangerous. Oregon's own opioid settlement implementation materials note that the risk of death from synthetic opioid overdose is dramatically higher in the first two weeks after release than in the general population. Those same materials also state that MOUD in jail settings can improve post-release treatment engagement, reduce illicit opioid use after release, and lower overdose risk. ([oregon.gov](https://www.oregon.gov/oha/PH/PREVENTIONWELLNESS/SUBSTANCEUSE/OPIOIDS/Documents/OHA%20implementation%20plan%20for%20allocation%20of%20opioid%20settlement%20funds.pdf))

That is why MAT in correctional settings is not just about comfort or compliance. It is about continuity of care, overdose prevention, and reducing the chance that someone leaves custody medically destabilized and untreated. For many people, incarceration is one of the few times they can be connected to treatment consistently. If that window is used well, it can change the trajectory of recovery. ([oregon.gov](https://www.oregon.gov/oha/PH/PREVENTIONWELLNESS/SUBSTANCEUSE/OPIOIDS/Documents/OHA%20implementation%20plan%20for%20allocation%20of%20opioid%20settlement%20funds.pdf))

How Oregon Is Structuring Jail-Based Treatment

Oregon has moved beyond general support for treatment and into specific jail-based funding and implementation. The Oregon Criminal Justice Commission runs the Jail-based Medications for Opioid Use Disorder Grant Program, created under House Bill 4002 in 2024. The stated purpose of the program is to provide opioid use disorder treatment and transition planning services to people in custody in local correctional facilities and tribal correctional facilities. ([oregon.gov](https://www.oregon.gov/cjc/jmoud/pages/default.aspx))

The state has also published formula funding allocations for 2025 to 2027, showing that many counties and facilities are receiving dedicated support for jail-based medications for opioid use disorder. The allocation list includes facilities such as Multnomah, Washington, Marion, Lane, Jackson, Lincoln, Malheur, and others, indicating that this is a statewide effort rather than a single-county experiment. ([oregon.gov](https://www.oregon.gov/cjc/jmoud/Documents/JMOUD_Formula_Funding_Table_2025-2027.pdf))

In practical terms, this means Oregon jails may use grant support to build or expand services such as:

• screening for opioid use disorder at intake
• continuing medication already prescribed in the community
• starting treatment in custody when clinically appropriate
• care coordination with community providers before release
• transition planning to reduce treatment gaps after discharge

The state's implementation materials also describe support for local jails to establish or improve MOUD services using methadone, buprenorphine formulations, or extended-release naltrexone. ([oregon.gov](https://www.oregon.gov/oha/PH/PREVENTIONWELLNESS/SUBSTANCEUSE/OPIOIDS/Documents/OHA%20implementation%20plan%20for%20allocation%20of%20opioid%20settlement%20funds.pdf))

What This Looks Like in Oregon Counties

Oregon's jail-based treatment landscape is not uniform, which is important to understand. Some counties have more developed programs, while others are still building capacity. A state "living list" of providers and partners shows active or developing opioid treatment connections in and around correctional settings across Oregon, including Lane County Jail, Washington County, Clackamas County, Jackson County, Josephine County, Klamath County, Douglas County Jail, Marion County, Multnomah County, Hood River, Jefferson, Deschutes, and others. ([oregon.gov](https://www.oregon.gov/adpc/SiteAssets/Lists/MeetingEvents/EditForm/living%20list%20of%20potential%20carcerial%20opioid%20providers%20and%20regions.pdf))

That variety matters because local jails differ in size, staffing, medical infrastructure, and access to community treatment partners. A large urban jail may have a corrections health team and multiple treatment partners. A smaller rural jail may rely more heavily on telemedicine, outside clinics, or regional providers. Oregon's funding and technical assistance model appears designed to help facilities at different stages of readiness move toward more consistent care. ([oregon.gov](https://www.oregon.gov/adpc/SiteAssets/Lists/MeetingEvents/EditForm/living%20list%20of%20potential%20carcerial%20opioid%20providers%20and%20regions.pdf))

Prisons, Reentry, and Continuity of Care

In Oregon's prison system, the Department of Corrections provides health services to adults in custody, including medical, behavioral health, and pharmacy services. The department's health and wellness materials emphasize ongoing treatment and coordinated care. That is significant because MAT works best when it is not treated as a one-time intervention, but as part of a longer treatment plan that continues through release. ([oregon.gov](https://www.oregon.gov/doc/inmate-services/pages/health-and-wellness.aspx))

Reentry is especially important. Oregon Health Authority's Oregon Health Plan reentry health care page shows that the state is also working on health coverage and care transitions for people leaving custody. While jail and prison systems are different, the policy direction is similar: reduce the gap between incarceration and community care so that people do not lose access to medications, appointments, or follow-up support at the moment they need it most. ([oregon.gov](https://www.oregon.gov/oha/hsd/ohp/pages/reentry.aspx))

Common Medications Used in MAT

In correctional settings, the most common medications for opioid use disorder are methadone, buprenorphine, and extended-release naltrexone. Oregon's jail MOUD materials specifically mention these options. Each medication works differently, and the right choice depends on the person's medical history, current treatment status, and clinical assessment. ([oregon.gov](https://www.oregon.gov/oha/PH/PREVENTIONWELLNESS/SUBSTANCEUSE/OPIOIDS/Documents/OHA%20implementation%20plan%20for%20allocation%20of%20opioid%20settlement%20funds.pdf))

• Methadone is a long-established treatment that can reduce withdrawal and cravings.
• Buprenorphine is widely used because it can be effective and easier to manage in many settings.
• Extended-release naltrexone may be appropriate for some people, especially when opioid-free induction is clinically suitable.

It is important to note that MAT is not a one-size-fits-all solution. Correctional health teams must balance safety, continuity, diversion concerns, and individual medical needs. Oregon's approach appears to recognize that complexity rather than pretending it does not exist. ([oregon.gov](https://www.oregon.gov/oha/PH/PREVENTIONWELLNESS/SUBSTANCEUSE/OPIOIDS/Documents/OHA%20implementation%20plan%20for%20allocation%20of%20opioid%20settlement%20funds.pdf))

Challenges Oregon Still Faces

Even with progress, medication-assisted treatment in jails and prisons remains difficult to implement. Oregon's own planning documents acknowledge that delivering MOUD in jails is complex and requires overcoming system barriers and clinical barriers. Those barriers can include staffing shortages, limited pharmacy access, security concerns, inconsistent intake screening, and the challenge of coordinating care across custody and community systems. ([oregon.gov](https://www.oregon.gov/oha/PH/PREVENTIONWELLNESS/SUBSTANCEUSE/OPIOIDS/Documents/OHA%20implementation%20plan%20for%20allocation%20of%20opioid%20settlement%20funds.pdf))

There is also the issue of consistency. A person's access to treatment should not depend entirely on which county jail they enter or whether they are transferred between facilities. Oregon's grant program and provider network suggest the state is trying to reduce those gaps, but implementation will likely remain uneven for some time. ([oregon.gov](https://www.oregon.gov/cjc/jmoud/pages/default.aspx))

Why This Matters for Public Safety and Public Health

MAT in correctional settings is often discussed as a health issue, but it also has public safety implications. When people leave custody with stable treatment, they are less likely to experience withdrawal-driven crises, less likely to return to illicit opioid use, and more likely to connect with community care. That can reduce emergency room visits, overdose deaths, and repeated justice-system involvement. Oregon's current policy direction reflects that broader understanding. ([oregon.gov](https://www.oregon.gov/oha/PH/PREVENTIONWELLNESS/SUBSTANCEUSE/OPIOIDS/Documents/OHA%20implementation%20plan%20for%20allocation%20of%20opioid%20settlement%20funds.pdf))

For families, this can mean a safer transition home. For counties, it can mean fewer preventable medical emergencies. For correctional staff, it can mean fewer crises inside facilities. And for people with opioid use disorder, it can mean the difference between a revolving door and a real path toward recovery.

Bottom Line

As of today, Oregon is actively expanding medication-assisted treatment in jails and supporting correctional health care in prisons through state agencies, grant programs, and reentry planning. The state's current strategy is grounded in a clear idea: opioid use disorder should be treated with evidence-based medical care, even in custody, and especially during the dangerous transition back to the community. ([oregon.gov](https://www.oregon.gov/cjc/jmoud/pages/default.aspx))

For Oregon, the real test is not whether MAT belongs in jails and prisons. That question has largely been answered. The test now is whether the state can make access consistent, sustainable, and connected to care after release.

Other Relevant Articles for Oregon

Relevant County Info

Information is sourced from publicaly available information and may be inaccurate